Department of Urology, Indiana University School of Medicine, Indianapolis, IN.
Department of Urology, Indiana University School of Medicine, Indianapolis, IN.
Urology. 2021 Jun;152:184-189. doi: 10.1016/j.urology.2020.12.036. Epub 2021 Jan 19.
To characterize the health-related quality of life reported by patients who received an ileal conduit (IC), Indiana pouch, or neobladder urinary diversion after radical cystectomy.
The Functional Assessment of Cancer Therapy-Vanderbilt Cystectomy Index survey was administered to patients with bladder cancer undergoing radical cystectomy and urinary diversion from 2015-2018. Surveys were completed prior to radical cystectomy and then longitudinally throughout the postoperative course.
A total of 146 patients completed questionnaires over a median of 12.3 months, 83 (56.8%) received an IC, 31 (21.2%) an Indiana pouch, and 32 (21.9%) an orthotopic neobladder. There were no significant differences in health related quality of life among urinary diversion groups considering the Trial Outcome Index scores, general overall FACT-G assessment, or total Functional Assessment of Cancer Therapy-Vanderbilt Cystectomy Index instruments. Patients who received IC were older and had higher Charlson Comorbidity Index scores (p <.005) yet still experienced similar improvements in health related quality of life commensurate with the other diversion cohorts. There was a significant difference in physical well-being favoring neobladder over IC or Indiana Pouch urinary diversions (p <.05).
To our knowledge this is the first and largest quality of life analysis comparing all three methods of urinary diversion in a longitudinal fashion utilizing a standardized, validated, treatment-specific health survey. Proper preoperative counseling is critical to ensure understanding of the benefits of available urinary diversion.
描述接受根治性膀胱切除术(RC)后行回肠导管(IC)、印第安纳袋或新膀胱尿流改道术的患者的健康相关生活质量。
对 2015-2018 年期间接受 RC 和尿流改道术的膀胱癌患者使用癌症治疗功能评估-范德比尔特膀胱切除术指数(Functional Assessment of Cancer Therapy-Vanderbilt Cystectomy Index,FACT-V)问卷进行调查。在 RC 术前及术后整个过程中进行了问卷调查。
共有 146 名患者在中位 12.3 个月的时间内完成了问卷,其中 83 名(56.8%)接受了 IC,31 名(21.2%)接受了印第安纳袋,32 名(21.9%)接受了原位新膀胱。在考虑试验结局指数评分、一般整体 FACT-G 评估或总癌症治疗功能评估-范德比尔特膀胱切除术指数工具时,各组尿流改道术患者的健康相关生活质量无显著差异。接受 IC 的患者年龄较大,Charlson 合并症指数评分较高(p<.005),但仍经历了与其他改道组相当的健康相关生活质量改善。新膀胱在身体幸福感方面明显优于 IC 或印第安纳袋(p<.05)。
据我们所知,这是首次使用标准化、验证过的、针对特定治疗的健康调查,以纵向方式比较三种尿流改道术的生活质量的最大分析。术前适当的咨询对于确保理解可用尿流改道的益处至关重要。